Articles tagged with Oligodendrocytes
A new study reveals that astrocytes actively participate in motor-learning circuit rewiring by eliminating synapses in the striatum. The research identifies MEGF10 as a key molecular mediator of this process, which is regulated by dopamine signaling and neural activity.
Scientists analyzed thousands of proteins in blood samples to understand when multiple sclerosis attacks the myelin sheath and nerve fibers. Researchers identified a protein called IL-3, which plays a key role in this early phase of damage.
Research reveals neuroglia play active role in brain function, driving disease progression through atrophy and functional decline. Therapeutic strategies targeting neuroglial signaling may prevent damage following brain injury or protect against neurodegenerative processes.
Laminin-411 protein and its derived peptide A4G47 exhibit pro-myelinating activity in oligodendrocytes, promoting myelin sheath formation. This discovery advances understanding of myelin sheath formation and potential applications for treating demyelinating diseases.
A rodent study found hnRNP A1 regulates myelin production and maintains its integrity, suggesting an impact on neurodegenerative diseases like schizophrenia. The findings provide new insights into the disease's molecular basis and potential treatments.
Regular aerobic exercise has been shown to significantly reduce disease markers associated with Alzheimer's, protecting healthy brain cells and restoring balance in the aging brain. The study highlights the potential for aerobic exercise to serve as a cornerstone in preventive strategies for Alzheimer's.
Scientists have discovered a natural compound called sulfuretin that can halt the progression of certain forms of cancer and demyelinating conditions like multiple sclerosis. The study found that sulfuretin blocks the activity of an enzyme involved in these diseases, suggesting its potential as a treatment.
Researchers at the Plasticity and Remodeling of Neural Circuits laboratory aim to stimulate myelin plasticity to regenerate affected nerve fibers in MS patients. The team will explore gene therapy, pharmacological approaches, and rehabilitation strategies to enhance myelin repair.
A new study published in The FEBS Journal found that protein C1QL1 plays a crucial role in promoting the replacement of specialized cells responsible for producing myelin. This discovery could lead to novel therapies for demyelinating diseases like multiple sclerosis.
A new study from the CUNY Graduate Center uncovers key mechanisms responsible for the transformation of adult progenitor cells into brain tumors. Researchers found that a specific combination of genetic mutations and growth factor overproduction drives this transformation, highlighting the importance of epigenetic changes in glioma dev...
Glial cells play a significant role in Alzheimer's disease, producing amyloid beta and contributing to plaque formation. Researchers discovered that knocking out BACE1 enzyme in oligodendrocytes reduced plaque formation by 30%, opening up new avenues for therapies.
Researchers have developed a new therapy called PIPE-307 that targets an elusive receptor on certain cells in the brain, prompting them to mature into myelin-producing oligodendrocytes. This could potentially reverse damage caused by multiple sclerosis, leading to improved movement, balance, and vision.
Oligodendrocyte-derived amyloid beta produces toxic peptide that promotes neuronal dysfunction in Alzheimer's disease. Selective suppression of oligodendrocyte Aβ production rescues abnormal neuronal hyperactivity, suggesting targeting these cells as a promising therapeutic strategy for AD.
Engineers at the University of California San Diego used a new technique called MUSIC to map out interactions between chromatin and RNA in individual brain cells. The study found that some brain cells age faster and are more prevalent in individuals with Alzheimer's disease, particularly in women.
Alexander Gow is studying the disease's effects on oligodendrocytes to provide new insight into the development and origins of MS. He aims to develop improved treatments by identifying a protein called Trb3 that may be a good drug target for the disease.
Researchers discovered that mature oligodendrocytes, critical for brain function, can survive for up to 45 days after a fatal trauma, defying the classical programmed cell-death pathway. This finding opens new avenues for understanding and potentially preventing damage caused by aging and neurodegenerative diseases.
Researchers from Case Western Reserve University found that common household chemicals harm oligodendrocytes, specialized cells that generate protective insulation around nerve cells. This discovery suggests a previously unrecognized risk factor for neurological diseases like multiple sclerosis and autism spectrum disorders.
Researchers found that ancient retroviruses are essential for myelin production in mammals, amphibians, and fish. The gene sequence RetroMyelin is likely a result of ancient viral infection, and its presence is necessary for myelination to occur.
In a mouse model of multiple system atrophy, alpha-synuclein overexpression induces neuroinflammation, demyelination, and neurodegeneration. IFNγ produced by infiltrating CD4+ T-cells mediates these changes. The study suggests that IFNγ is a potential future disease-modifying therapeutic target.
Researchers have uncovered the molecular and ultrastructural features of BCAS1+ cells in diffuse gliomas, highlighting their proliferative capacity and distribution. The study provides a comprehensive characterization of the BCAS1+ cell population within diffuse gliomas, shedding light on its role in tumor malignancy.
A team of neuroscientists has discovered that oligodendrocytes, myelin-forming cells, accelerate glucose consumption to deliver energy-rich molecules to rapidly firing axons. This communication is mediated by potassium signals and maintains axonal health.
Researchers discovered that a little-understood synapse in the brain plays a pivotal role in producing myelin, the protective sheath around nerve cells. This finding could lead to new therapies for multiple sclerosis, neurodegenerative conditions and brain cancer.
Researchers found an inverse relationship between axon loss and demyelination, suggesting that 'bad' myelin can be more damaging than its absence. This study identifies potential therapeutic targets for diseases associated with myelin defects and inflammation in the nervous system.
A Pitt Professor believes oligodendrocytes, the nerve insulating cells, hold the solution to BCI's nagging problem. By understanding and preserving these cells, researchers aim to improve BCI's performance and expand its applications beyond paralysis.
Researchers found that young and healthy human glial progenitor cells can outcompete older and diseased cells in the adult brain, replacing them with healthier ones. This breakthrough has strong therapeutic implications for treating neurological disorders like Huntington's disease.
A team of researchers found that a small population of nerve cells exists in everyone that could be coaxed to regrow, potentially restoring sight and movement. The discovery provides new insights into how axons grow and could lead to effective therapies for blindness, paralysis, and other disorders caused by nerve damage.
Researchers at Duke-NUS Medical School have identified a special transporter protein that regulates the formation of myelin sheaths in the brain, which protect nerves from damage. The study suggests that omega-3 fatty acid lipids play a crucial role in directing oligodendrocyte development, a process critical for brain myelination.
Researchers developed a novel tool to monitor recovery after CNS demyelination, enabling early testing of pro-remyelinating strategies. This new approach shows promising results in reducing clinical failure and advancing therapeutic success for multiple sclerosis.
Researchers at UC Davis discovered how oligodendrocyte-lineage cells transfer cell material to neurons in the mouse brain, providing a new mechanism for understanding brain maturation and finding treatments for neurological conditions. This discovery opens new possibilities for treating neurodegenerative diseases like Alzheimer's and P...
A study on Mea6-deficient mice reveals significantly affected gross and microstructure of white matter, altered lipid composition, and reduced expression of elongation of very long chain fatty acids proteins. This research provides insight into the pathogenesis of white matter diseases.
A University of Alberta researcher has found that fractalkine triggers the repair of brain damage caused by multiple sclerosis, leading to increased production of vital brain cells. This discovery could potentially halt or reverse MS symptoms by replacing damaged cells with new ones.
Researchers at Aarhus University are developing a novel treatment for multiple sclerosis by spinning artificial nerve fibers using electro-spun fibres. The goal is to restore nerve impulses quickly, as the myelin sheath deteriorates with age.
UCSF researchers identified glioma's cellular source of recurrent disease, finding cells shift to mesenchymal, radiation-resistant phenotype in response to standard therapy. Paracrine signals from tumor microenvironment drive this transition through AP1 pathway, leading to therapy resistance and tumor recurrence.
Researchers have discovered that oligodendrocyte precursor cells (OPCs) play a crucial role in synaptic pruning, cleaning up unwanted connections between neurons. By analyzing a massive dataset of 3D brain cell structures, the team found OPCs digesting parts of neighboring neurons.
Research reveals that oligodendrocyte precursor cells (OPCs) contribute to the pruning process, helping shape a healthy brain during early development. OPCs actively engulf synapses, eliminating connections that are no longer needed, and play an intermediary role between external experiences and brain activity.
Researchers replaced zebrafish GPR17 receptor gene with human version to study myelin repair in multiple sclerosis. Testing substances in modified fish larvae may lead to quicker and more successful human trials.
The study proposes a model to understand the complications caused by zika virus infection during pregnancy. The researchers found that zika virus alters protein expression in neural cells, affecting energy production and RNA metabolism, which can lead to defective myelination and microcephaly.
A new study identifies how the suppression of a specific transcription gene triggers changes that impair oligodendrocyte function in Huntington's disease. The researchers believe replacing or fixing defective glia cells may prove a far easier proposition than replenishing neurons lost in the disease.
A new study demonstrates that glyphosate successfully crosses the blood-brain barrier and enhances TNF-α levels in mice. The herbicide is linked to increased production of soluble beta amyloid and reduced neuron viability, suggesting potential hazards to neurological health.
Researchers discover that neurons directly contribute to Krabbe disease destruction through enzyme galactosylceramidase. This finding presents a new approach to developing therapies for the rare neurodegenerative disorder.
A study found that high blood adenosine levels at 15 days of life correlated with white matter lesions and brain injury in very low birth weight premature infants. Adenosine may play a role in oligodendrocyte maturation and neuronal development, suggesting its potential as a biomarker for complications of prematurity.
Researchers at Niigata University identified a novel Olig2 binding protein called Ddx20, which regulates RNA metabolism and transcription. Ddx20's interaction with Olig2 helps maintain cell survival and prevents apoptosis in neural progenitor cells.
Researchers identified key differences in metabolic processes between brain and spinal cord oligodendrocytes, which could lead to new therapeutic treatments for neurodegenerative diseases. The study also found that targeting a specific cell protein may enhance cholesterol and myelin production.
A study published in Neuron suggests that oligodendrocytes and immune cells may play a crucial role in multiple sclerosis (MS) development. The research found that genetic mutations near immune genes can activate nearby genes in oligodendrocytes, potentially leading to misfunction and MS risk.
Researchers found increased myelination in areas associated with emotions and memory in individuals with anxiety and PTSD, correlating with specific symptoms. This study provides a possible explanation for individual variation in stress response and may lead to targeted treatments.
A recent NIH study identifies oligodendrocytes as a key player in maintaining energy levels within axons, which are essential for long-distance communication. The research discovered that oligodendrocytes release an enzyme called SIRT2, which increases mitochondrial activity and provides a local power boost to axons.
A new study suggests that existing drugs for multiple sclerosis may not be effective due to toxic blood leaks in the brain. Researchers have identified a promising alternative treatment option that could improve myelin repair, even in the presence of these harmful elements.
A recent study discovered that brain cells cannot maintain the myelin sheath in the absence of the TDP-43 protein. Restoring cholesterol levels has been proposed as a potential therapeutic strategy for neurodegenerative diseases associated with TDP-43. The research found that oligodendrocytes, responsible for producing myelin, have def...
A study using protein mapping reveals that abnormal glutamate levels in the brains of schizophrenic patients can lead to oxidative stress and apoptosis in neurons, while oligodendrocytes display different responses. This knowledge may contribute to the development of more targeted treatments for schizophrenia.
Researchers found that HIV prevents oligodendrocytes from maturing, reducing myelin production. The virus secretes glutamate, which activates the integrated stress response, further disrupting cell development.
A study by Boston University School of Medicine researchers has identified significant alterations in white matter, including loss of oligodendrocytes and changes to oligodendroglial subtypes, in CTE brains. These findings may lead to new treatments for the progressive brain disease associated with repetitive head trauma.
A new study found that myelin loss is a major factor in age-related brain deterioration, leading to cognitive decline and neurodegenerative diseases. The researchers identified a key gene responsible for the reduced efficiency of cells that produce myelin with age.
Oligodendrocytes form a key part of the brain's energy supply network, working alongside astrocytes to transport energy-rich compounds to synapses. Without this network, neurons can't communicate effectively.
A new study reveals that mouse ependymal cells have latent potential to differentiate into oligodendrocytes, which provide protective insulation for neural wiring. This finding suggests an alternative approach to spinal cord repair by leveraging resident stem cells.
Researchers discovered a potential way to prevent long-lasting brain damage in newborn children by targeting the histamine H2 receptor. A protein known as the histamine H2 receptor inhibits the formation of mature oligodendrocytes, leading to improved recovery from hypoxia-ischemia in mice treated with cimetidine.
Researchers at CU School of Medicine have discovered that precise motor learning stimulates cellular processes to improve recovery after nerve cell damage. The study found that mature oligodendrocytes can contribute to repairing the nervous system by generating new myelin sheaths.
Researchers at Oregon Health & Science University have developed a compound that successfully promotes rebuilding of damaged nerve cell protective sheath, reversing MS symptoms. The discovery may lead to clinical trials in humans with MS or other neurodegenerative conditions.
Researchers identify glial cells as critical players in brain's response to social stress. The study found that oligodendrocytes, the myelin-producing cells, play a key role in determining individual resilience or susceptibility to stressful events.
The NINDS R35 grant will fund the Casaccia lab's work to elucidate signals regulating oligodendrocyte progenitor cells in healthy brains, addressing normal and dysfunctional cell behavior. This award supports long-term research on regenerative properties of progenitor cells and their role in neurological diseases.
A new study from the University of Virginia identifies a compound that can recruit oligodendrocytes, a type of glial cell, to repair damage in the peripheral nervous system. This finding has implications for treating debilitating neurological disorders such as muscular dystrophy and Charcot-Marie-Tooth disease.